Chronic methamphetamine-induced catecholaminergic degeneration and cognitive dysfunction
Chronic methamphetamine-induced catecholaminergic degeneration and cognitive dysfunction
批准号:
10597529
负责人:
Alexander N Pilski
金额:
$4.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-01-14 至 2025-01-13
关键词:
AstrocytesAttenuatedAutomobile DrivingAxonBackBehavioralBiological AssayCRISPR/Cas technologyCatecholaminesChronicCytosolDataDeaminationDependenceDiseaseDopamineEnzymesFunctional disorderGeneticGoalsImmunofluorescence ImmunologicImpaired cognitionImpairmentKnock-outKnowledgeLengthLesionMentorsMetabolismMethamphetamineMitochondriaMonoamine OxidaseMorphologyMusNerve DegenerationNeuronsNeurosciencesNeurotransmittersNorepinephrinePatternPilot ProjectsPopulationProcessProteinsReactive Oxygen SpeciesResearchSalineScientistSeveritiesStimulantStressSubstantia nigra structureTechniquesTestingTrainingVesicleaxon injuryaxonal degenerationbehavioral impairmentcareerconditioned feardopaminergic neurongenetic manipulationimprovedlocus ceruleus structuremultidisciplinaryneuronal cell bodyneuroprotectionnovelobject recognitionpars compactapharmacologicpreventpsychostimulantvesicular monoamine transporter 2
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Methamphetamine (meth) is a powerfully addictive psychostimulant capable of causing neuronal damage.
Recent studies by my mentor, Dr. Graves, found that meth increases mitochondrial stress in the axons of
substantia nigra pars compacta (SNc) dopamine (DA) neurons resulting from MAO metabolism of cytosolic DA.
Pilot studies showed similar effects in the axons of Locus coeruleus (LC) norepinephrine (NE) neurons. Using
a 28-day meth administration paradigm, recent studies by Dr. Graves found degeneration of SNc DA neurons
and that pharmacological inhibition of MAO was neuroprotective. Pilot studies similarly show chronic meth-
induced LC degeneration that is attenuated by MAO inhibition. These data suggest that axonal MAO-
dependent mitochondrial stress contributes to chronic meth-induced degeneration. The overarching goal of
this proposal is to determine the progression and presentation of degeneration, whether neuronal (as opposed
to astrocytic) MAO enzymes are necessary for degeneration, and the behavioral consequences of chronic
meth-induced SNc and LC degeneration. My central hypothesis is that chronic meth induces a neuronal
MAO-dependent dying-back pattern of SNc and LC degeneration resulting in cognitive impairment and
will be tested in the following aims: Aim 1: Determine if chronic meth produces a dying-back pattern of SNc
and LC degeneration. Meth increases axonal, but not somatic MAO-dependent mitochondrial stress, and MAO
inhibition prevented chronic meth-induced SNc and LC degeneration; these data suggest that MAO-dependent
axonal mitochondrial stress drives degeneration. I therefore hypothesize that chronic meth will produce a
dying-back pattern of SNc and LC degeneration, where axonal loss precedes somatic loss. Aim 2: Determine
if neuronal MAO is necessary for chronic meth-induced SNc and LC degeneration. Studies show systemic
MAO inhibition prevented chronic meth-induced SNc and LC degeneration, but MAO enzymes are expressed
in neurons and astrocytes. Given that meth increased mitochondrial stress in SNc and LC axons, I hypothesize
that neuronal MAO is necessary for degeneration. Aim 3: Determine the behavioral consequences of chronic
meth-induced SNc and LC degeneration. SNc degeneration and LC lesioning are associated with impairments
in novel object recognition and context-associated fear conditioning assays, respectively; I therefore
hypothesize that chronic meth-induced degeneration of the SNc and LC will lead to similar behavioral
impairments. I will test my hypotheses by training in and using immunofluorescence, unbiased stereological
assessment of neuronal and axonal degeneration, behavioral analysis, and both genetic and pharmacological
inhibition of MAO enzymes. Testing my hypotheses will provide me with outstanding technical and conceptual
training as a research scientist. Completion of proposed aims will improve our understanding of the
neurodegenerative consequences of chronic meth, expanding knowledge of catecholaminergic degeneration
and providing value to the study of disorders involving similar degeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chronic methamphetamine-induced catecholaminergic degeneration and cognitive dysfunction
-
批准号:10464353
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2022
-
负责人:Alexander N Pilski
-
依托单位:
海外基金